Investor Stock List
Ranked #3,365 of 8,699 institutional investors

Trails Edge Capital Partners, LP

Atlanta, GA

$568M
US stock portfolio at live prices · today −$7.0M (−1.22%)
Live prices, last trade 10:48 AM ET
Value at quarter end (Q3 2026)
$696M
Change from Q2 2026
+$66.0M (+10.48%)
Positions
34 · 7 new, 5 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$28.4M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
LBRX 7.96%BMRN 7.18%TRAX 6.06%OBX 5.29%IMCR 4.96%
StockSharesValue, live% of portfoliovs Q2 2026
LBRX LB Pharmaceuticals Inc1,149,240$45.2M7.96%Reduced −25%
BMRN BioMarin Pharmaceutical Inc.667,000$40.8M7.18%Added +30%
TRAX First Tracks Biotherapeutics, Inc.814,000$34.4M6.06%Reduced −46%
OBX Obsidian Therapeutics, Inc.2,495,660$30.1M5.29%New
IMCR Immunocore Holdings plc1,063,234$28.2M4.96%Unchanged
CYTK Cytokinetics, Incorporated470,000$24.7M4.35%Added +63%
TNGX Tango Therapeutics, Inc.1,100,000$24.6M4.32%New
FDMT 4D Molecular Therapeutics, Inc.2,227,917$23.8M4.19%Unchanged
DSGN Design Therapeutics, Inc.2,500,000$23.3M4.09%Added +25%
NGNE Neurogene Inc.964,885$21.8M3.84%Added +35%
CLDX Celldex Therapeutics, Inc.765,000$21.0M3.70%New
NRIX Nurix Therapeutics, Inc.1,573,220$20.8M3.65%Unchanged
TYRA Tyra Biosciences, Inc.1,000,000$20.2M3.56%New
MLTX MoonLake Immunotherapeutics1,680,000$18.5M3.25%Added +124%
XENE Xenon Pharmaceuticals Inc.400,000$15.0M2.65%Reduced −9%
CTNM Contineum Therapeutics, Inc.1,693,694$14.9M2.62%New
CAMP Camp4 Therapeutics Corp3,625,576$14.0M2.47%Added +88%
INBX Inhibrx Biosciences, Inc.170,000$12.4M2.19%New
IKT Inhibikase Therapeutics, Inc.9,110,112$12.0M2.11%Added +1%
KLRA Kailera Therapeutics, Inc.942,953$10.8M1.90%Reduced −4%
AVTX Avalo Therapeutics, Inc.1,500,000$10.2M1.79%Added +68%
AURA Aura Biosciences, Inc.1,443,333$10.0M1.75%Unchanged
IRD Opus Genetics, Inc.2,411,657$9.5M1.67%Reduced −12%
IVA Inventiva S.A.2,657,997$8.8M1.55%Unchanged
FTH Faeth Therapeutics, Inc.941,689$8.1M1.43%Added +83%
XFOR X4 Pharmaceuticals, Inc.2,571,478$7.7M1.35%Unchanged
TRDA Entrada Therapeutics, Inc.1,428,440$6.4M1.12%New
ALT Altimmune, Inc.4,230,000$5.8M1.03%Added +59%
IPSC Century Therapeutics, Inc.4,134,969$5.0M0.88%Unchanged
IMA ImageneBio, Inc.1,094,045$4.1M0.73%Added +288%
NERV Minerva Neurosciences, Inc.1,419,000$3.0M0.52%Unchanged
PMN ProMIS Neurosciences, Inc.557,103$1.8M0.31%Unchanged
OKUR OnKure Therapeutics, Inc.619,557$1.7M0.30%Reduced −57%
VTVT vTv Therapeutics Inc.76,989$1.3M0.22%Reduced −10%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
INSM Insmed Incorporated230,331$33.5M
MIRM Mirum Pharmaceuticals, Inc.223,312$21.7M
RVMD Revolution Medicines, Inc.115,750$19.1M
INCY Incyte Corporation155,000$18.0M
SNDX Syndax Pharmaceuticals, Inc.1,110,000$10.1M